Apricus Biosciences Company Profile (NASDAQ:APRI)

About Apricus Biosciences

Apricus Biosciences logoApricus Biosciences, Inc. is a pharmaceutical company, which develops pharmaceutical products. The Company primarily focuses on the development and commercialization of products and product candidates in the areas of urology and rheumatology. The Company's drug delivery technology is a permeation enhancer called NexACT. The Company has over two product candidates in Phase II development, fispemifene for the treatment of symptomatic male secondary hypogonadism and RayVa for the treatment of Raynaud's phenomenon, secondary to scleroderma. The Company has a commercial product, Vitaros for the treatment of erectile dysfunction (ED), which is in development in the United States, approved in Canada and marketed throughout Europe.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: APRI
  • CUSIP:
Key Metrics:
  • Previous Close: $2.89
  • 50 Day Moving Average: $2.1688
  • 200 Day Moving Average: $1.2156
  • 52-Week Range: $7,733,000.00 - $0.26
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -35.63
  • P/E Growth: 0.0000
  • Market Cap: $24.79B
  • Outstanding Shares: 7,733,000
  • Beta: 0.26
Profitability:
  • Net Margins: -117.82%
  • Return on Assets: -134.36%
Debt:
  • Current Ratio: 0.57%
  • Quick Ratio: 0.51%
Additional Links:
Companies Related to Apricus Biosciences:

Analyst Ratings

Consensus Ratings for Apricus Biosciences (NASDAQ:APRI) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $2.95 (7.99% downside)

Analysts' Ratings History for Apricus Biosciences (NASDAQ:APRI)
Show:
DateFirmActionRatingPrice TargetDetails
3/15/2016Taglich BrothersLower Price TargetSpeculative Buy$4.25 -> $2.95View Rating Details
3/11/2016Dawson JamesReiterated RatingBuyView Rating Details
12/9/2015Sterne Agee CRTDowngradeBuy -> NeutralView Rating Details
11/6/2015Roth CapitalDowngradeBuy -> Neutral$1.50View Rating Details
8/13/2015Ascendiant Capital MarketsInitiated CoverageBuy$2.50View Rating Details
(Data available from 2/19/2015 forward)

Earnings

Earnings History for Apricus Biosciences (NASDAQ:APRI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/7/2017        
11/8/2016Q316($0.60)($0.19)$1.91 million$4.30 millionViewListenView Earnings Details
8/4/2016Q216($0.08)($0.05)$1.52 millionViewListenView Earnings Details
5/9/2016Q116($0.09)($0.09)ViewN/AView Earnings Details
3/9/2016Q415($0.11)($0.05)$1.81 million$2.60 millionViewListenView Earnings Details
11/5/2015Q315($0.11)($0.10)$1.42 million$1.30 millionViewListenView Earnings Details
8/5/2015Q2($0.13)($0.10)ViewListenView Earnings Details
5/11/2015Q1($0.10)($0.13)ViewListenView Earnings Details
3/16/2015Q4($0.12)($0.09)$1.90 millionViewListenView Earnings Details
11/10/2014Q314($0.10)($0.08)$1.23 million$1.90 millionViewN/AView Earnings Details
8/12/2014Q214($0.04)$0.05$5.45 million$5.50 millionViewN/AView Earnings Details
5/12/2014Q114($0.03)($0.09)$2.83 millionViewN/AView Earnings Details
3/17/2014Q212($0.06)($0.04)$2.00 million$0.36 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Apricus Biosciences (NASDAQ:APRI)
Current Year EPS Consensus Estimate: $-1.4500 EPS
Next Year EPS Consensus Estimate: $-0.0900 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.09)($0.08)($0.09)
Q2 20162($0.10)($0.06)($0.08)
Q3 20162($0.08)($0.07)($0.08)
Q4 20162($0.24)($0.05)($0.15)
Q1 20171($0.04)($0.04)($0.04)
Q2 20171($0.01)($0.01)($0.01)
Q3 20171($0.02)($0.02)($0.02)
Q4 20171$0.01$0.01$0.01
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Apricus Biosciences (NASDAQ:APRI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Apricus Biosciences (NASDAQ:APRI)
Insider Ownership Percentage: 3.21%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/3/2016Alexander J DennerMajor ShareholderBuy6,647,728$0.88$5,850,000.64View SEC Filing  
1/12/2016Alexander J DennerMajor ShareholderBuy1,306,819$0.88$1,150,000.72View SEC Filing  
12/29/2014Brian DorseyInsiderBuy10,000$1.05$10,500.00View SEC Filing  
12/22/2014Richard W PascoeCEOBuy10,000$1.02$10,200.00View SEC Filing  
10/23/2014Sandford D SmithDirectorBuy26,500$1.57$41,605.00View SEC Filing  
1/3/2014Leonard A OppenheimDirectorSell15,212$2.49$37,877.88View SEC Filing  
12/26/2013Kleanthis G XanthopoulosDirectorSell17,184$2.55$43,819.20View SEC Filing  
6/21/2013Kleanthis G XanthopoulosDirectorSell2,864$2.52$7,217.28View SEC Filing  
5/23/2013Richard W PascoeCEOBuy35,000$2.85$99,750.00View SEC Filing  
5/23/2013Rusty RayDirectorBuy5,000$2.85$14,250.00View SEC Filing  
5/23/2013Steven Robert MartinCFOBuy20,000$2.85$57,000.00View SEC Filing  
5/21/2013Kleanthis G XanthopoulosDirectorSell2,864$3.36$9,623.04View SEC Filing  
8/20/2012Edward M CoxVPBuy1,500$2.73$4,095.00View SEC Filing  
8/17/2012Rusty RayDirectorBuy4,000$2.81$11,240.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Apricus Biosciences (NASDAQ:APRI)
DateHeadline
News IconAnalyst Target Price Look at Apricus Biosciences, Inc. (NASDAQ:APRI) Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Rives Journal (NASDAQ:APRI)
rivesjournal.com - February 18 at 3:32 PM
News IconApricus Biosciences, Inc. (APRI) loses confidence of 9 hedge fund ... - Post Analyst (NASDAQ:APRI)
postanalyst.com - February 18 at 3:32 PM
News IconThe Bears And Bulls Square Off On Apricus Biosciences, Inc. (APRI) - NY Stock News (NASDAQ:APRI)
nystocknews.com - February 18 at 9:40 AM
News IconEPS Of Apricus Biosciences, Inc (NASDAQ:APRI) At $0.01 - Stock Observer (NASDAQ:APRI)
www.thestockobserver.com - February 16 at 3:39 PM
gurufocus.com logoApricus Biosciences Receives Positive Nasdaq Listing Determination - GuruFocus.com (NASDAQ:APRI)
www.gurufocus.com - February 10 at 9:04 PM
News IconPulse Biosciences, Inc. Company Profile (NASDAQ:APRI)
www.bioportfolio.com - February 10 at 4:03 PM
finanznachrichten.de logoApricus Biosciences, Inc.: Apricus Biosciences Receives Positive Nasdaq Listing Determination (NASDAQ:APRI)
www.finanznachrichten.de - February 10 at 1:47 AM
us.rd.yahoo.com logo6:04 am Apricus Biosciences notified that the Nasdaq has granted its request for continued listing pursuant to an extension through May 30, 2017 (NASDAQ:APRI)
us.rd.yahoo.com - February 10 at 1:47 AM
streetinsider.com logoApricus Biosciences (APRI) Announces Receipt of Positive Nasdaq Listing Determination - StreetInsider.com (NASDAQ:APRI)
www.streetinsider.com - February 9 at 3:42 PM
biz.yahoo.com logoAPRICUS BIOSCIENCES, INC. Files SEC form 8-K, Other Events (NASDAQ:APRI)
biz.yahoo.com - February 9 at 3:42 PM
finance.yahoo.com logoApricus Biosciences to Present at the 19th Annual BIO CEO & Investor Conference - Yahoo Finance (NASDAQ:APRI)
finance.yahoo.com - February 8 at 8:50 PM
News IconCompany Watch: Checking the Numbers on Shares of Apricus Biosciences Inc. (APRI) - Piedmont Register (NASDAQ:APRI)
piedmontregister.com - February 8 at 3:47 PM
nasdaq.com logoApricus Biosciences to Present at the 19th Annual BIO CEO & Investor Conference - Nasdaq (NASDAQ:APRI)
www.nasdaq.com - February 8 at 3:47 PM
finance.yahoo.com logoApricus Biosciences to Present at the 19th Annual BIO CEO & Investor Conference (NASDAQ:APRI)
finance.yahoo.com - February 8 at 3:47 PM
News IconMarket Focus: Checking in on Shares of Apricus Biosciences Inc. (APRI) - Rives Journal (NASDAQ:APRI)
rivesjournal.com - February 8 at 2:26 AM
News IconNews Impact Score Of Apricus Biosciences, Inc (NASDAQ:APRI) At 100 - Stock Observer (NASDAQ:APRI)
www.thestockobserver.com - February 7 at 4:23 PM
News IconLong term Growth Analysis of Apricus Biosciences, Inc (NASDAQ:APRI) - The Newburgh Press (NASDAQ:APRI)
newburghpress.com - February 3 at 3:42 PM
News IconIncrease in Volatility Draws Attention to Shares of Apricus Biosciences, Inc. (NASDAQ:APRI) - Nelson Research (NASDAQ:APRI)
nelsonobserver.com - February 2 at 8:40 PM
News IconSignal Watch: Checking the Numbers for Apricus Biosciences Inc. (APRI) - Sherwood Daily (NASDAQ:APRI)
sherwooddaily.com - February 2 at 3:38 PM
News IconIncrease in Volatility Draws Attention to Shares of Apricus Biosciences, Inc. (NASDAQ:APRI) - Wall Street Beacon (NASDAQ:APRI)
wsbeacon.com - February 1 at 8:46 PM
News IconCan This Stock Make a Ripple in the Market: Apricus Biosciences, Inc. (NASDAQ:APRI) - Prospect Journal (NASDAQ:APRI)
prospectjournal.com - February 1 at 3:44 PM
News IconNews Impact Score Of Apricus Biosciences, Inc (NASDAQ:APRI) At 80 - Stock Observer (NASDAQ:APRI)
www.thestockobserver.com - January 31 at 8:49 PM
News IconNotable Stock For Under $5: Apricus Biosciences, Inc. (NASDAQ:APRI) - Prospect Journal (NASDAQ:APRI)
prospectjournal.com - January 31 at 3:45 PM
News IconStock Vacillating as Volatility Hits a High Point For Apricus Biosciences, Inc. (NASDAQ:APRI) - Wall Street Beacon (NASDAQ:APRI)
wsbeacon.com - January 31 at 3:45 PM
investornewswire.com logoSales Estimates Of Apricus Biosciences, Inc (NASDAQ:APRI) At $10.165 - Investor Newswire (NASDAQ:APRI)
www.investornewswire.com - January 30 at 9:40 PM
News IconTraders are Taking a Closer Look at These Shares: Apricus Biosciences Inc. (APRI) - Sherwood Daily (NASDAQ:APRI)
sherwooddaily.com - January 30 at 9:40 PM
News IconNewsworthy Wonder Stock: Penny Stock Investors Looking at Apricus Biosciences, Inc. (NASDAQ:APRI) - Nelson Research (NASDAQ:APRI)
nelsonobserver.com - January 29 at 3:32 PM
News IconMeasuring the Levels on Shares of Apricus Biosciences Inc. (APRI) - Sherwood Daily (NASDAQ:APRI)
sherwooddaily.com - January 27 at 4:25 PM
News IconPeering into Recent Action from Apricus Biosciences, Inc. (NASDAQ:APRI) - Prospect Journal (NASDAQ:APRI)
prospectjournal.com - January 27 at 4:25 PM
finance.yahoo.com logoThursday’s Top Biopharma Movers (NASDAQ:APRI)
finance.yahoo.com - January 27 at 1:54 AM
News IconRange Watch on Technical Indicators for Apricus Biosciences Inc. (APRI) - Sherwood Daily (NASDAQ:APRI)
sherwooddaily.com - January 26 at 3:51 PM
News IconStock Seesawing as Volatility Sweeps in on Apricus Biosciences, Inc. (NASDAQ:APRI) - Wall Street Beacon (NASDAQ:APRI)
wsbeacon.com - January 26 at 3:51 PM
News IconNear-Term, Can This Stock Move the Needle: Apricus Biosciences, Inc. (NASDAQ:APRI) - Prospect Journal (NASDAQ:APRI)
prospectjournal.com - January 25 at 8:41 PM
News IconFocus on RSI and CCI Levels: Apricus Biosciences Inc. (APRI) - Sherwood Daily (NASDAQ:APRI)
sherwooddaily.com - January 25 at 3:41 PM
News IconEnlivened Volatility Spotted in Shares of Apricus Biosciences, Inc. (NASDAQ:APRI) - Wall Street Beacon (NASDAQ:APRI)
wsbeacon.com - January 25 at 3:41 PM
News IconNews Impact Score Of Apricus Biosciences, Inc (NASDAQ:APRI) At 90 - Stock Observer (NASDAQ:APRI)
www.thestockobserver.com - January 24 at 3:45 PM
News IconPriming The Pump: Stock Volatility Spotted in Apricus Biosciences, Inc. (NASDAQ:APRI) - Wall Street Beacon (NASDAQ:APRI)
wsbeacon.com - January 23 at 8:40 PM
News IconNoteworthy Stocks to Watch for: Apricus Biosciences, Inc. (NASDAQ:APRI), American Eagle Outfitters, Inc. (NYSE:AEO) - The Newburgh Press (NASDAQ:APRI)
newburghpress.com - January 23 at 3:39 PM
News IconApricus Biosciences, Inc (APRI) Broker Price Targets For The Coming Week (NASDAQ:APRI)
myhealthbowl.com - January 22 at 4:57 AM
News IconAmplified Volatility Spotted in Shares of Apricus Biosciences, Inc. (NASDAQ:APRI) - Wall Street Beacon (NASDAQ:APRI)
wsbeacon.com - January 21 at 2:36 AM
News IconHere's The Real Reason Apricus Biosciences Inc (NASDAQ:APRI) Is ... - Insider Financial (NASDAQ:APRI)
www.insiderfinancial.com - January 21 at 2:36 AM
News IconGOP Growing Furious Dems are Block Trump Nominees (NASDAQ:APRI)
baddgoddess.com - January 20 at 9:34 PM
News IconBrokers Add To Their Ratings On Neurocrine Biosciences, Inc. (NASDAQ:NBIX) (NASDAQ:APRI)
latribunadecanarias.com - January 20 at 4:33 PM
News IconVolume Explodes in Apricus Biosciences Inc (NASDAQ:APRI) Following Mexican Market Approval of Vitaros® (NASDAQ:APRI)
streetregister.com - January 20 at 4:44 AM
News IconNext Weeks Broker Price Targets For Apricus Biosciences, Inc (APRI) (NASDAQ:APRI)
xboxonezone.com - January 19 at 9:38 PM
News IconMover to Watch: Apricus Biosciences Inc (NASDAQ:APRI) (NASDAQ:APRI)
vgtoday.net - January 19 at 9:38 PM
finanznachrichten.de logoApricus Biosciences, Inc.: Apricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in Mexico (NASDAQ:APRI)
www.finanznachrichten.de - January 18 at 4:12 PM
streetinsider.com logoApricus Biosciences (APRI) Vitaros Approved in Mexico for Erectile Dysfunction (NASDAQ:APRI)
www.streetinsider.com - January 18 at 4:12 PM
News IconApricus Biosciences Inc: Why APRI Stock Is Skyrocketing (NASDAQ:APRI)
www.profitconfidential.com - January 18 at 4:12 PM
finance.yahoo.com logoApricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in Mexico (NASDAQ:APRI)
finance.yahoo.com - January 18 at 4:11 PM

Social

What is Apricus Biosciences' stock symbol?

Apricus Biosciences trades on the NASDAQ under the ticker symbol "APRI."

Where is Apricus Biosciences' stock going? Where will Apricus Biosciences' stock price be in 2017?

2 analysts have issued 12-month target prices for Apricus Biosciences' shares. Their forecasts range from $2.95 to $2.95. On average, they expect Apricus Biosciences' stock price to reach $2.95 in the next twelve months.

When will Apricus Biosciences announce their earnings?

Apricus Biosciences is scheduled to release their next quarterly earnings announcement on Tuesday, March, 7th 2017.

Who owns Apricus Biosciences stock?

Apricus Biosciences' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Sarissa Capital Management LP (18.72%).

Who bought Apricus Biosciences stock? Who is buying Apricus Biosciences stock?

Apricus Biosciences' stock was purchased by a variety of institutional investors in the last quarter, including Sarissa Capital Management LP.

How do I buy Apricus Biosciences stock?

Shares of Apricus Biosciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Apricus Biosciences stock cost?

One share of Apricus Biosciences stock can currently be purchased for approximately $3.21.

Apricus Biosciences (NASDAQ:APRI) Chart for Sunday, February, 19, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Apricus Biosciences (NASDAQ:APRI)

Earnings History Chart

Earnings by Quarter for Apricus Biosciences (NASDAQ:APRI)

Dividend History Chart

Dividend Payments by Quarter for Apricus Biosciences (NASDAQ:APRI)

Last Updated on 2/19/2017 by MarketBeat.com Staff